JP2025510161A5 - - Google Patents
Info
- Publication number
- JP2025510161A5 JP2025510161A5 JP2024556499A JP2024556499A JP2025510161A5 JP 2025510161 A5 JP2025510161 A5 JP 2025510161A5 JP 2024556499 A JP2024556499 A JP 2024556499A JP 2024556499 A JP2024556499 A JP 2024556499A JP 2025510161 A5 JP2025510161 A5 JP 2025510161A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide compound
- solvate
- salt
- peptide
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263323831P | 2022-03-25 | 2022-03-25 | |
| US63/323,831 | 2022-03-25 | ||
| PCT/CA2023/050401 WO2023178449A1 (en) | 2022-03-25 | 2023-03-24 | Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510161A JP2025510161A (ja) | 2025-04-14 |
| JP2025510161A5 true JP2025510161A5 (https=) | 2026-03-30 |
Family
ID=88099462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556499A Pending JP2025510161A (ja) | 2022-03-25 | 2023-03-24 | ガストリン放出ペプチド受容体（ｇｒｐｒ）のインビボイメージング及びｇｒｐｒ関連障害の治療のための放射性標識化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12246076B2 (https=) |
| EP (1) | EP4499663A1 (https=) |
| JP (1) | JP2025510161A (https=) |
| KR (1) | KR20250007523A (https=) |
| CN (1) | CN119213011A (https=) |
| AU (1) | AU2023239751A1 (https=) |
| CA (1) | CA3246188A1 (https=) |
| IL (1) | IL315057A (https=) |
| WO (1) | WO2023178449A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025054727A1 (en) * | 2023-09-13 | 2025-03-20 | Provincial Health Services Authority | Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843903A (en) | 1995-11-27 | 1998-12-01 | The Administrators Of The Tulane Educational Fund | Targeted cytotoxic anthracycline analogs |
| EP2100900A1 (en) | 2008-03-07 | 2009-09-16 | Universitätsspital Basel | Bombesin analog peptide antagonist conjugates |
| EP2198878A1 (en) | 2008-12-18 | 2010-06-23 | University Of Miami | Polypeptide bombesin antagonists |
| ES2745635T3 (es) | 2012-09-25 | 2020-03-03 | Advanced Accelerator Applications Usa Inc | Antagonistas de GRPR para la detección, diagnóstico y tratamiento del cáncer positivo para GRPR |
| WO2021068051A1 (en) | 2018-11-13 | 2021-04-15 | Provincial Health Services Authority | Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders |
| TWI878344B (zh) * | 2019-09-17 | 2025-04-01 | 瑞士商諾華公司 | 放射性標記grpr拮抗劑之方法及其套組 |
-
2023
- 2023-03-24 AU AU2023239751A patent/AU2023239751A1/en active Pending
- 2023-03-24 WO PCT/CA2023/050401 patent/WO2023178449A1/en not_active Ceased
- 2023-03-24 CN CN202380029657.8A patent/CN119213011A/zh active Pending
- 2023-03-24 JP JP2024556499A patent/JP2025510161A/ja active Pending
- 2023-03-24 KR KR1020247035353A patent/KR20250007523A/ko active Pending
- 2023-03-24 EP EP23773418.1A patent/EP4499663A1/en active Pending
- 2023-03-24 IL IL315057A patent/IL315057A/en unknown
- 2023-03-24 CA CA3246188A patent/CA3246188A1/en active Pending
- 2023-11-17 US US18/512,708 patent/US12246076B2/en active Active
-
2025
- 2025-02-03 US US19/043,780 patent/US20250195702A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025161856A5 (https=) | ||
| JP2022548875A5 (https=) | ||
| JP2025510161A5 (https=) | ||
| JP2021530451A5 (https=) | ||
| JP2021191784A5 (https=) | ||
| JP2021503490A5 (https=) | ||
| JP2019218375A5 (https=) | ||
| CA2319672A1 (en) | Compounds and compositions for delivering active agents | |
| JP2010526089A5 (https=) | ||
| JP2018076328A5 (https=) | ||
| JP2019532083A5 (https=) | ||
| JP2024010073A5 (https=) | ||
| CN105436701B (zh) | 镁基金属与铝基金属的连接方法 | |
| JP2005525345A5 (https=) | ||
| JP2012503661A5 (https=) | ||
| JP2009510255A5 (https=) | ||
| CA2405136A1 (en) | Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents | |
| JP2020523327A5 (https=) | ||
| RU2734930C2 (ru) | Режимы дозирования мелфлуфена для раковых заболеваний | |
| JP2025507971A5 (https=) | ||
| JP2022507214A5 (https=) | ||
| JP2020524670A5 (https=) | ||
| JP2024528127A5 (https=) | ||
| JPH10147529A5 (https=) | ||
| JP2007502303A5 (https=) |